Trio pharmaceuticals and ajinomoto bio pharma services enter into a development collaboration for a...
Trio Pharmaceuticals, Inc., a cancer therapeutics company developing novel dual action antibody drugs, and Ajinomoto...
Gilead’s drug remdesivir gets US FDA’s emergency use authorisation for COVID-19
Gilead was granted EUA by U.S. FDA for the investigational antiviral remdesivir to treat COVID-19....
Inspirata Hosts Fireside Chat on the Future of Pathology in a Post-COVID-19 World
Cancer informatics and digital pathology solution provider Inspirata is setting its sights on the post-COVID-19...
MedPharm Develops Model to Support Coronavirus Pharmaceutical Development
MedPharm, a leading clinical development organization in topical and transdermal drug delivery, has expanded its...
ARTES Biotech to Develop VLP SARS-CoV-2 Vax Candidates
ARTES Biotechnology, a biotech company specializing in process development for recombinant vaccines, entered development of...
Sino-Pack2020 and PACKINNO2020 will be further postponed from June 2020 to March 2021
Postponement of the 27th China International Exhibition on Packaging Machinery & Materials (Sino-Pack2020) cum China...
Bio-Rad Begins Shipping COVID-19 Antibody Test
Bio-Rad Laboratories has launched its SARS-CoV-2 Total Ab test, a blood-based immunoassay kit to help...
Q BioMed, Mannin Research Accelerate COVID-19 Response Initiatives
Q BioMed Inc., and its technology partner, Mannin Research, are accelerating the rapid development of...
Cytovance and Akshaya Bio Announce Collaboration Agreement of Therapeutics for Treatment of Coronavirus and...
Cytovance Biologics, a contract development and manufacturing organization (CDMO) and a subsidiary of the Shenzhen...
Queen’s University leading cell therapy clinical trial to help improve outcomes in COVID-19 patients
Researchers at Queen’s University Belfast are leading a UK-wide clinical trial, offering an innovative cell...
